expressTEC Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $230K

  • Investors
  • 6

expressTEC General Information

Description

Operator of a biotechnology startup intended to provide quick access to personalized therapies for cancer patients. The company developed RNA-based diagnostic tests to revolutionize clinical testing, selecting patients with greater precision and efficiency for targeted therapies, enabling patients to optimize treatment results.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Incubadora da Universidade de Algarve
  • Campus de Gambelas Pavilhão B1
  • Faro, 8005-226
  • Portugal
+351 289
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Decision/Risk Analysis
Other Devices and Supplies
Drug Discovery
Corporate Office
  • Incubadora da Universidade de Algarve
  • Campus de Gambelas Pavilhão B1
  • Faro, 8005-226
  • Portugal
+351 289

expressTEC Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

expressTEC Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Angel (individual) 01-Oct-2025 $230K Completed Product Development
7. Grant 01-Jan-2025 Completed Product Development
6. Grant 18-Mar-2024 Completed Product In Beta Test
5. Grant 12-Dec-2023 Completed Product In Beta Test
4. Grant 23-Nov-2023 Completed Startup
3. Seed Round 17-Nov-2023 Completed Startup
2. Accelerator/Incubator 20-Jul-2022 Completed Startup
1. Accelerator/Incubator Completed Startup
To view expressTEC’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

expressTEC Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

expressTEC Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sotavento Angels Angel Group Minority
SantanderX Accelerator/Incubator
Portugal Telecom Inovacao Corporation
Portugal Ventures Venture Capital Minority
Agência Nacional de Inovação Government
You’re viewing 5 of 6 investors. Get the full list »

expressTEC FAQs

  • When was expressTEC founded?

    expressTEC was founded in 2022.

  • Where is expressTEC headquartered?

    expressTEC is headquartered in Faro, Portugal.

  • What is the size of expressTEC?

    expressTEC has 7 total employees.

  • What industry is expressTEC in?

    expressTEC’s primary industry is Discovery Tools (Healthcare).

  • Is expressTEC a private or public company?

    expressTEC is a Private company.

  • What is expressTEC’s current revenue?

    The current revenue for expressTEC is .

  • How much funding has expressTEC raised over time?

    expressTEC has raised $337K.

  • Who are expressTEC’s investors?

    Sotavento Angels, SantanderX, Portugal Telecom Inovacao, Portugal Ventures, and Agência Nacional de Inovação are 5 of 6 investors who have invested in expressTEC.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process